About Zinc finger protein 383
Zinc finger protein 383 (ZNF383) is a protein
from Homo sapiens identified by UniProt accession
Q8NA42, 475 residues long.
MolForge cross-references it against 0 known binders and
14 disease associations.
Target properties
| Protein name | Zinc finger protein 383 |
| UniProt accession | Q8NA42 |
| Gene | ZNF383 |
| Organism | Homo sapiens |
| Length | 475 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (14)
Diseases linked to this target (Open Targets).
- BMI-adjusted waist circumference · score 0.05
- hematocrit · score 0.04
- BMI-adjusted waist-hip ratio · score 0.04
- smoking status measurement · score 0.04
- grip strength measurement · score 0.03
- hemoglobin measurement · score 0.03
- body height · score 0.03
- insomnia · score 0.02
- eosinophil count · score 0.02
- erythrocyte count · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NA42-F1 | alphafold | PREDICTED | 73.53 | — |
Amino-acid sequence (475 residues)
MAEGSVMFSD VSIDFSQEEW DCLDPVQRDL YRDVMLENYG NLVSMGLYTP KPQVISLLEQ GKEPWMVGRE LTRGLCSDLE SMCETKLLSL KKEVYEIELC QREIMGLTKH GLEYSSFGDV LEYRSHLAKQ LGYPNGHFSQ EIFTPEYMPT FIQQTFLTLH QIINNEDRPY ECKKCGKAFS QNSQFIQHQR IHIGEKSYEC KECGKFFSCG SHVTRHLKIH TGEKPFECKE CGKAFSCSSY LSQHQRIHTG KKPYECKECG KAFSYCSNLI DHQRIHTGEK PYECKVCGKA FTKSSQLFQH ARIHTGEKPY ECKECGKAFT QSSKLVQHQR IHTGEKPYEC KECGKAFSSG SALTNHQRIH TGEKPYDCKE CGKAFTQSSQ LRQHQRIHAG EKPFECLECG KAFTQNSQLF QHQRIHTDEK PYECNECGKA FNKCSNLTRH LRIHTGEKPY NCKECGKAFS SGSDLIRHQG IHTNK
Explore Zinc finger protein 383 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets